Comprehensive Support for Women’s Health Through Femtech
First written in FY2023-Q2. 2 of 3 entries say "Restated". Latest entry: FY2025.
0 other companies' latest entry also says "Restated".
- FY2025RestatedAnnual report
「Building on this business platform, we aim to achieve sustainable growth and contribute to society through business development and investment in related fields, including regenerative medicine and femtech.」
The policy of pursuing business development and investment in related fields, including regenerative medicine and femtech, based on the cell banking business is continuing. - FY2023-Q3RestatedAnnual report
「We are also actively promoting new businesses, including a femtech business providing comprehensive support for women's health in collaboration with major operating companies, with a view to launching them next fiscal year.」
Promotion of the femtech business, including collaboration with major operating companies, is continuing with a view to launching it next fiscal year. - FY2023-Q2First statedAnnual report
「We will also actively promote new business development, including a femtech business that provides comprehensive support for women's health in collaboration with major operating companies.」
A femtech business providing comprehensive support for women's health through collaboration with major operating companies was listed for the first time as a candidate for new business development.